A Molecular Case Series: Deep Cellular and Spatial Epigenetic Characterization of Human Colorectal Cancer

分子案例系列:人类结直肠癌的深层细胞和空间表观遗传特征

基本信息

  • 批准号:
    10677611
  • 负责人:
  • 金额:
    $ 4.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-01 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Cancer has long been thought of as a disease caused by genetic mutations that enable a cell to grow out of control. However, there is growing awareness of the importance of epigenetic aberrations – disruptions in the systems that control the transcriptional potential of genes – in cancer initiation and progression. Sufficient levels of DNA methyltransferase activity, which are responsible for the deposition of DNA methylation (an important epigenetic mark), have been shown to be necessary for formation of intestinal polyps in mouse models of colorectal cancer (CRC). Furthermore, hypermethylation of many genetic loci has been noted in CRC tissue samples. These hypermethylated loci are significantly enriched in genes targeted by the polycomb repressive complex (Polycomb Target Genes or PTGs), which play important roles in development and differentiation. Thus, suppression of PTGs by aberrant DNA methylation could contribute to the development and progression of CRC. However, it is unclear when and where these PTG hypermethylation (PTGH) events arise. They may arise as a result of genetic mutations, but studies of the cancer genome have failed to find any mutation linked to PTGH. Also, PTGH events have been found in histologically normal colorectal tissue. Thus, it is possible that PTGH accumulates over time in normal colorectal tissue, with excessive levels of this mark allowing malignant transformation. If this is the case, at least some PTGH events should be found clonally (in every cell of a tumor), because they existed in the founding cell of the tumor. The experiments outlined here are designed to test this model by constructing a detailed map of DNA methylation in human colorectal tumors and adjacent mucosa. Specifically, they aim to test the hypotheses that 1) PTGH exists in tumor-adjacent colorectal mucosa in a spatial and cellular distribution consistent with accumulation over time, and that 2) PTGH events are clonally present within CRC tumors. To achieve these goals, the proposed studies use bulk and single-cell whole-genome bisulfite sequencing techniques to measure genome-wide DNA methylation at single-base resolution. These studies will greatly strengthen our understanding of the cellular and spatial distribution of PTGH in CRC, giving us a better understanding of when and where this mark arises. Ultimately, these findings could help to develop more sensitive screening tests or earlier treatments for colorectal cancer. These studies will be conducted as part of the applicant’s training in a joint MD-PhD program sponsored by Michigan State University College of Human Medicine and Van Andel Institute (VAI). VAI provides a rich environment for research training, combining ample scientific resources with opportunities to learn from world- class scientists in a focused setting. The applicant will receive mentorship from leading experts in the field of DNA methylation, single-cell analysis, and bioinformatics, as well as many opportunities for collaboration, professional development, and continued clinical activity throughout the training program.
项目摘要/摘要 长期以来,癌症一直被认为是一种由使细胞生长的基因突变引起的疾病 失控了。然而,越来越多的人意识到表观遗传异常的重要性--在 控制基因转录潜力的系统--在癌症的发生和发展中。足够 DNA甲基转移酶活性水平,这是导致DNA甲基化(And)沉积的原因 重要的表观遗传标记),已经被证明是在小鼠模型中形成肠息肉所必需的 结直肠癌(CRC)。此外,在结直肠癌组织中已经注意到许多基因位点的高甲基化。 样本。这些高甲基化的基因显著富含多梳状抑制基因 复合体(多梳靶基因或PTG),在发育和分化中发挥重要作用。因此, 通过异常的DNA甲基化抑制PTGs可能有助于结直肠癌的发生和发展。 然而,目前还不清楚这些PTG超甲基化(PTGH)事件发生的时间和地点。他们可能会 是由基因突变引起的,但对癌症基因组的研究未能发现任何与此有关的突变 致PTGH。此外,在组织学上正常的大肠组织中也发现了PTGH事件。因此,有可能 随着时间的推移,PTGH在正常的结直肠组织中积累,过量的PTGH标记允许恶性 转型。如果是这样的话,至少应该克隆地(在肿瘤的每个细胞中)发现一些PTGH事件, 因为它们存在于肿瘤的创始细胞中。这里概述的实验旨在测试这一点 通过构建人类结直肠肿瘤及邻近粘膜DNA甲基化的详细图谱,建立了该模型。 具体地说,他们的目标是检验这样的假设:1)PTGH存在于肿瘤附近的大肠粘膜中 细胞分布与随时间积累一致,2)甲状旁腺激素事件呈克隆性存在 在结直肠癌肿瘤内。为了实现这些目标,拟议的研究使用批量和单细胞全基因组 以单碱基分辨率测量全基因组DNA甲基化的亚硫酸氢盐测序技术。这些 研究将极大地加强我们对结直肠癌中PTGH细胞和空间分布的理解,给出 我们更好地了解了这一标志何时何地出现。最终,这些发现可能有助于开发 对结直肠癌进行更敏感的筛查测试或更早的治疗。 这些研究将作为申请者在医学博士联合项目中培训的一部分进行 由密歇根州立大学人类医学院和范安德尔研究所(VAI)共同完成。VAI提供了丰富的 科研培训环境,将丰富的科学资源与向世界学习的机会相结合- 全神贯注的环境中的一流科学家。申请者将得到该领域顶尖专家的指导 DNA甲基化、单细胞分析和生物信息学,以及许多合作机会, 专业发展,以及在整个培训计划中持续的临床活动。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nathan J. Spix其他文献

High-coverage allele-resolved single-cell DNA methylation profiling reveals cell lineage, X-inactivation state, and replication dynamics
高覆盖率等位基因解析的单细胞 DNA 甲基化分析揭示了细胞谱系、X 染色体失活状态和复制动态
  • DOI:
    10.1038/s41467-025-61589-1
  • 发表时间:
    2025-07-08
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Nathan J. Spix;Walid Abi Habib;Zhouwei Zhang;Emily Eugster;Hsiao-yun Milliron;David Sokol;KwangHo Lee;Paula A. Nolte;Jamie L. Endicott;Kelly F. Krzyzanowski;Toshinori Hinoue;Jacob Morrison;Benjamin K. Johnson;Wanding Zhou;Hui Shen;Peter W. Laird
  • 通讯作者:
    Peter W. Laird

Nathan J. Spix的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nathan J. Spix', 18)}}的其他基金

A Molecular Case Series: Deep Cellular and Spatial Epigenetic Characterization of Human Colorectal Cancer
分子案例系列:人类结直肠癌的深层细胞和空间表观遗传特征
  • 批准号:
    10537774
  • 财政年份:
    2022
  • 资助金额:
    $ 4.67万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 4.67万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 4.67万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.67万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了